Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 5Cablivi
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 61
2018 Revenue in Millions : 4
Growth (%) : 1,300
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 137
2019 Revenue in Millions : 68
Growth (%) : 102
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 181
2020 Revenue in Millions : 123
Growth (%) : 45
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 231
2021 Revenue in Millions : 181
Growth (%) : 28
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 245
2022 Revenue in Millions : 231
Growth (%) : 8
